https://www.medicines.org.uk/emc/product/15030/pil
Mavacamten BMS 5 mg hard capsules - Patient Information Leaflet (PIL) - (emc) | 15030
Mavacamten BMS 5 mg hard capsules - Patient Information Leaflet (PIL) by Bristol Myers Squibb Pharmaceuticals limited
patient information leaflet5 mghard capsules
https://www.healthdirect.gov.au/medicines/medicinal-product/aht,27149/mavacamten
Mavacamten | healthdirect
More information is available on Mavacamten including side effects, age restrictions, food interactions, whether the medicine is available at a government...
mavacamtenhealthdirect
https://www.mdpi.com/2077-0383/12/20/6628
Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is a genetic disease characterized by an increased left ventricular wall thickness in the absence of increased afterload...
alcohol septal ablationmavacamtenhypertrophiccardiomyopathy
https://www.acc.org/latest-in-cardiology/articles/2026/03/25/21/27/sun-1045am-scout-acc-2026
SCOUT-HCM: Mavacamten Benefits Adolescents With oHCM - American College of Cardiology
american collegescouthcmmavacamtenbenefits
https://www.acc.org/latest-in-cardiology/articles/2022/04/02/13/22/sun-945am-treatment-mavacamten-acc-2022
Efficacy, Safety of Mavacamten in Treating Obstructive HCM Holds Up in EXPLORER-LTE Cohort of...
https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2023/12/07/15/59/mavacamten-a-first-in-class
Mavacamten for Obstructive HCM: Key Points - American College of Cardiology
key pointsamerican collegemavacamtenhcmcardiology
https://www.adnkronos.com/Archivio/salute/farmaci-risultati-positivi-per-mavacamten-in-adolescenti-con-cardiomiopatia-ipertrofica_7pfAVgbVY0VoDcNwRpSjQ3
Farmaci, risultati positivi per mavacamten in adolescenti con cardiomiopatia ipertrofica
Esperti, 'l'inibitore della miosina cardiaca potrebbe diventare la prima terapia farmacologica mirata per la patologia'
farmacirisultatipositivipermavacamten